MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Preference and Satisfaction of the Deep Brain Stimulation Battery in the Patients with Hypokinetic Movement Disorders

X. Qiu, CC. Zhang, Z.Y Lin, Y.H Wang, Y.W Wu, D.Y Li (Shanghai, China)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1318

Keywords: Deep brain stimulation (DBS)

Category: Surgical Therapy: Other Movement Disorders

Objective: To evaluate the preference and satisfaction of the deep brain stimulation implantable pulse generator in patients with hypokinetic movement disorders.

Background: Deep brain stimulation (DBS) is an established treatment for movement disorder. Implantable pulse generators (implantable pulse generators/batteries) for DBS can be chosen between fixed-life and rechargeable batteries, with each having their advantages and disadvantages. This study aimed to evaluate patients’ preferences and long-term satisfaction with their choice of DBS.

Method: 92 patients diagnosed with dystonia or tics undergoing DBS surgery were given a questionnaire to assess long-term satisfaction and experience with the type of battery they had chosen, and the influenced factors on the decision.

Results: Of these ninety-two patients, seventy-one was diagnosed with dystonia and twenty-one with tics. 52.2% patients sought DBS surgery after referrals from neurology specialists. The social media was also a non-negligible way for the popularization of the DBS (32.6%, 30/91). Interestingly, the remote programming feature significantly affected patients’ choice between products of domestic and imported brands (χ2 = 5.05, p = 0.02). 85.9% patients satisfied with stimulating effects as well as the implanted device. 78.3% patients chose a rechargeable device (r-IPG). The choice between rechargeable and the non-rechargeable device was significantly associated with the patient’s affordability (χ2 = 19.07, p = 0.00). 33.3% (24/72) felt confident using their r-IPG within one week after discharge. 66.7% (48/72) of patients with r-IPG checked the device battery every week. The mean interval for battery recharge was 4.4 days. 18.1% (13/72) of r-IPG patients need partners or nursing services to check and recharge the IPG. Similarly, the percentage of patients who continued to work was 41.7% (30/72). However, only a minority (30.0%, 9/30) recharged during the work. There are nine patients claimed the experience of the recharge problem, four of whom needed technical support.

Conclusion: Most of the patients are satisfied with their choice of IPG. And the patients’ economic status is the most important factor of choice on the IPG. The skill of using rechargeable implanted pulse generator was easily to be capable by most patients.

To cite this abstract in AMA style:

X. Qiu, CC. Zhang, Z.Y Lin, Y.H Wang, Y.W Wu, D.Y Li. Preference and Satisfaction of the Deep Brain Stimulation Battery in the Patients with Hypokinetic Movement Disorders [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/preference-and-satisfaction-of-the-deep-brain-stimulation-battery-in-the-patients-with-hypokinetic-movement-disorders/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/preference-and-satisfaction-of-the-deep-brain-stimulation-battery-in-the-patients-with-hypokinetic-movement-disorders/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley